ISIBLOOM Drug Patent Profile
✉ Email this page to a colleague
When do Isibloom patents expire, and when can generic versions of Isibloom launch?
Isibloom is a drug marketed by Xiromed and is included in one NDA.
The generic ingredient in ISIBLOOM is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isibloom
A generic version of ISIBLOOM was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12th, 1999.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ISIBLOOM?
- What are the global sales for ISIBLOOM?
- What is Average Wholesale Price for ISIBLOOM?
Summary for ISIBLOOM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Drug Prices: | Drug price information for ISIBLOOM |
| DailyMed Link: | ISIBLOOM at DailyMed |
US Patents and Regulatory Information for ISIBLOOM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xiromed | ISIBLOOM | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 202789-001 | Aug 12, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
